Ataxia-telangiectasia (A-T) is a rare neurodegenerative disorder caused by the deficiency of the serine/threonine kinase ataxia telangiectasia mutated (ATM) protein, whose loss of function leads to altered cell cycle, apoptosis, oxidative stress balance and DNA repair after damage. The clinical manifestations are multisystemic, among them cerebellar degeneration and muscular ataxia. The molecular mechanism by which ATM loss leads to A-T is still uncertain and, currently only symptomatic treatments are available. In this study, we generated a functional skeletal muscle cell model that recapitulates A-T and highlights the role of ATM in calcium signalling and muscle contraction. To this aim, by using CRISPR/Cas9 technology, we knocked out the ATM protein in urine-derived stem cells (USCs) from healthy donors. The resulting USCs-ATM-KO maintained stemness but showed G2/S cell cycle progression and an inability to repair DNA after UV damage. Moreover, they showed increased cytosolic calcium release after ATP stimulation to the detriment of the mitochondria. The alterations of calcium homoeostasis were maintained after differentiation of USCs-ATM-KO into skeletal muscle cells (USC-SkMCs) and correlated with impaired cell contraction. Indeed, USC-SkMCs-ATM-KO contraction kinetics were dramatically accelerated compared to control cells. These results highlight the relevant function of ATM in skeletal muscle, which is not only dependent on a non-functional neuronal communication, paving the way for future studies on a muscular interpretation of A-T ataxia.

ATM knock out alters calcium signalling and augments contraction in skeletal muscle cells differentiated from human urine-derived stem cells

Boni G.;Pendin D.;
2025

Abstract

Ataxia-telangiectasia (A-T) is a rare neurodegenerative disorder caused by the deficiency of the serine/threonine kinase ataxia telangiectasia mutated (ATM) protein, whose loss of function leads to altered cell cycle, apoptosis, oxidative stress balance and DNA repair after damage. The clinical manifestations are multisystemic, among them cerebellar degeneration and muscular ataxia. The molecular mechanism by which ATM loss leads to A-T is still uncertain and, currently only symptomatic treatments are available. In this study, we generated a functional skeletal muscle cell model that recapitulates A-T and highlights the role of ATM in calcium signalling and muscle contraction. To this aim, by using CRISPR/Cas9 technology, we knocked out the ATM protein in urine-derived stem cells (USCs) from healthy donors. The resulting USCs-ATM-KO maintained stemness but showed G2/S cell cycle progression and an inability to repair DNA after UV damage. Moreover, they showed increased cytosolic calcium release after ATP stimulation to the detriment of the mitochondria. The alterations of calcium homoeostasis were maintained after differentiation of USCs-ATM-KO into skeletal muscle cells (USC-SkMCs) and correlated with impaired cell contraction. Indeed, USC-SkMCs-ATM-KO contraction kinetics were dramatically accelerated compared to control cells. These results highlight the relevant function of ATM in skeletal muscle, which is not only dependent on a non-functional neuronal communication, paving the way for future studies on a muscular interpretation of A-T ataxia.
2025
Istituto di Neuroscienze - IN - Sede Secondaria Padova
Istituto di Scienze e Tecnologie Chimiche "Giulio Natta" - SCITEC
stem cells
CRISPR/Cas9
mitochondria
atm
File in questo prodotto:
File Dimensione Formato  
Dematteis_et_al-2025-Cell_Death_Discovery.pdf

accesso aperto

Descrizione: articolo pubblicato
Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 10.59 MB
Formato Adobe PDF
10.59 MB Adobe PDF Visualizza/Apri
supp figures.pdf

accesso aperto

Descrizione: supplementary figures
Tipologia: Altro materiale allegato
Licenza: Creative commons
Dimensione 551.31 kB
Formato Adobe PDF
551.31 kB Adobe PDF Visualizza/Apri
supp table 1.pdf

accesso aperto

Descrizione: supplementary table 1
Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 187.38 kB
Formato Adobe PDF
187.38 kB Adobe PDF Visualizza/Apri
supp table 2.pdf

accesso aperto

Descrizione: supplementary table 2
Tipologia: Altro materiale allegato
Licenza: Creative commons
Dimensione 165.97 kB
Formato Adobe PDF
165.97 kB Adobe PDF Visualizza/Apri
41420_2025_2485_MOESM4_ESM.pdf

accesso aperto

Descrizione: supplementary information
Tipologia: Altro materiale allegato
Licenza: Creative commons
Dimensione 258.22 kB
Formato Adobe PDF
258.22 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/552813
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact